Clinical and Serological Findings of Madariaga and Venezuelan Equine Encephalitis Viral Infections: A Follow-up Study 5 Years After an Outbreak in Panama
- PMID: 33005697
- PMCID: PMC7518370
- DOI: 10.1093/ofid/ofaa359
Clinical and Serological Findings of Madariaga and Venezuelan Equine Encephalitis Viral Infections: A Follow-up Study 5 Years After an Outbreak in Panama
Abstract
Background: Human cases of Madariaga virus (MADV) infection were first detected during an outbreak in 2010 in eastern Panama, where Venezuelan equine encephalitis virus (VEEV) also circulates. Little is known about the long-term consequences of either alphavirus infection.
Methods: A follow-up study of the 2010 outbreak was undertaken in 2015. An additional survey was carried out 2 weeks after a separate 2017 alphavirus outbreak in a neighboring population in eastern Panama. Serological studies and statistical analyses were undertaken in both populations.
Results: Among the originally alphavirus-seronegative participants (n = 35 of 65), seroconversion was observed at a rate of 14.3% (95% CI, 4.8%-30.3%) for MADV and 8.6% (95% CI, 1.8%-23.1%) for VEEV over 5 years. Among the originally MADV-seropositive participants (n = 14 of 65), VEEV seroconversion occurred in 35.7% (95% CI, 12.8%-64.9%). In the VEEV-seropositive participants (n = 16 of 65), MADV seroconversion occurred in 6.3% (95% CI, 0.2%-30.2%). MADV seroreversion was observed in 14.3% (95% CI, 1.8%-42.8%) of those who were originally seropositive in 2010. VEEV seroconversion in the baseline MADV-seropositive participants was significantly higher than in alphavirus-negative participants. In the population sampled in 2017, MADV and VEEV seroprevalence was 13.2% and 16.8%, respectively. Memory loss, insomnia, irritability, and seizures were reported significantly more frequently in alphavirus-seropositive participants than in seronegative participants.
Conclusions: High rates of seroconversion to MADV and VEEV over 5 years suggest frequent circulation of both viruses in Panama. Enhanced susceptibility to VEEV infection may be conferred by MADV infection. We provide evidence of persistent neurologic symptoms up to 5 years following MADV and VEEV exposure.
Keywords: Madariaga virus; Panama; Venezuelan equine encephalitis virus; neurological sequelae.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Similar articles
-
Endemic and Epidemic Human Alphavirus Infections in Eastern Panama: An Analysis of Population-Based Cross-Sectional Surveys.Am J Trop Med Hyg. 2020 Dec;103(6):2429-2437. doi: 10.4269/ajtmh.20-0408. Epub 2020 Oct 22. Am J Trop Med Hyg. 2020. PMID: 33124532 Free PMC article.
-
Epidemiology of Emergent Madariaga Encephalitis in a Region with Endemic Venezuelan Equine Encephalitis: Initial Host Studies and Human Cross-Sectional Study in Darien, Panama.PLoS Negl Trop Dis. 2016 Apr 21;10(4):e0004554. doi: 10.1371/journal.pntd.0004554. eCollection 2016 Apr. PLoS Negl Trop Dis. 2016. PMID: 27101567 Free PMC article.
-
Human and Equine Infection with Alphaviruses and Flaviviruses in Panamá during 2010: A Cross-Sectional Study of Household Contacts during an Encephalitis Outbreak.Am J Trop Med Hyg. 2018 Jun;98(6):1798-1804. doi: 10.4269/ajtmh.17-0679. Epub 2018 May 3. Am J Trop Med Hyg. 2018. PMID: 29737271 Free PMC article.
-
Characteristics of Madariaga and Venezuelan Equine Encephalitis Virus Infections, Panama.Emerg Infect Dis. 2024;30(14):94-104. doi: 10.3201/eid3014.240182. Emerg Infect Dis. 2024. PMID: 39530903 Free PMC article. Review.
-
Uncertainties Surrounding Madariaga Virus, a Member of the Eastern Equine Encephalitis Virus Complex.Vector Borne Zoonotic Dis. 2024 Oct;24(10):633-640. doi: 10.1089/vbz.2023.0162. Epub 2024 May 8. Vector Borne Zoonotic Dis. 2024. PMID: 38717063 Review.
Cited by
-
Mapping Eastern (EEE) and Venezuelan Equine Encephalitides (VEE) among Equines Using Geographical Information Systems, Colombia, 2008-2019.Viruses. 2023 Mar 8;15(3):707. doi: 10.3390/v15030707. Viruses. 2023. PMID: 36992416 Free PMC article.
-
Real-time RT-PCR for Venezuelan equine encephalitis complex, Madariaga, and Eastern equine encephalitis viruses: application in human and mosquito public health surveillance in Panama.J Clin Microbiol. 2023 Dec 19;61(12):e0015223. doi: 10.1128/jcm.00152-23. Epub 2023 Nov 20. J Clin Microbiol. 2023. PMID: 37982611 Free PMC article.
-
Induction of systemic and mucosal immune response against Zika virus by vaccination with non-infectious chimeric VLPs.Sci Rep. 2025 Jul 10;15(1):24834. doi: 10.1038/s41598-025-07059-6. Sci Rep. 2025. PMID: 40640219 Free PMC article.
-
The dynamic landscape of emerging viral infections.Pediatr Res. 2024 Jan;95(2):411-413. doi: 10.1038/s41390-023-02974-8. Epub 2023 Dec 22. Pediatr Res. 2024. PMID: 38135723 No abstract available.
-
Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.Virology. 2022 Jan 2;565:13-21. doi: 10.1016/j.virol.2021.09.007. Epub 2021 Sep 28. Virology. 2022. PMID: 34626907 Free PMC article.
References
-
- Navarro J-C, Carrera J-P, Liria J, et al. . Alphaviruses in Latin America and the introduction of chikungunya virus. In: Ludert, JE, Pujol F, Arbiza J, eds. Human Virology in Latin America. Cham, Switzerland: Springer International Publishing; 2017:169–92.